EP Patent

EP1575542A1 — Aerosol delivery systems

Assigned to MC2 Therapeutics Ltd · Expires 2005-09-21 · 21y expired

What this patent protects

An aerosol composition which is prepared from a biliquid foam, an aqueous phase and a propellant, and wherein an oil soluble functional material is incorporated into the biliquid foam during preparation to enable this material to be more readily incorporated into the composition.…

USPTO Abstract

An aerosol composition which is prepared from a biliquid foam, an aqueous phase and a propellant, and wherein an oil soluble functional material is incorporated into the biliquid foam during preparation to enable this material to be more readily incorporated into the composition. The aerosol composition can be contained in a pressurized aerosol can and can be a polish, an air freshener, a repellant. a pre- or post-shave preparation, a shaving preparation or a follicle softener.

Drugs covered by this patent

Patent Metadata

Patent number
EP1575542A1
Jurisdiction
EP
Classification
—
Expires
2005-09-21
Drug substance claim
No
Drug product claim
No
Assignee
MC2 Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.